Literature DB >> 24985130

MYC and the control of apoptosis.

Steven B McMahon1.   

Abstract

MYC expression is tightly correlated with cell-cycle progression in normal tissues, whereas unchecked MYC expression is among the most prominent hallmarks of the hyperproliferation associated with most forms of cancer. At first glance it might seem counterintuitive that MYC is also among the most robust agents of programmed cell death (apoptosis) in mammalian cells. However it is clearly beneficial for a multicellular organism to have a mechanism for triggering death in cells that express potentially oncogenic levels of MYC. Decades of intense study have begun to provide an understanding of the mechanisms that regulate MYC's seemingly split personality. Key features of MYC-induced apoptosis will be discussed here along with examples of how our understanding of this pathway might be exploited for the therapeutic benefit of cancer patients.
Copyright © 2014 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24985130      PMCID: PMC4066641          DOI: 10.1101/cshperspect.a014407

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  60 in total

1.  Egr1 mediates p53-independent c-Myc-induced apoptosis via a noncanonical ARF-dependent transcriptional mechanism.

Authors:  David N Boone; Ying Qi; Zhaoliang Li; Stephen R Hann
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-27       Impact factor: 11.205

2.  Induction of apoptosis in fibroblasts by c-myc protein.

Authors:  G I Evan; A H Wyllie; C S Gilbert; T D Littlewood; H Land; M Brooks; C M Waters; L Z Penn; D C Hancock
Journal:  Cell       Date:  1992-04-03       Impact factor: 41.582

3.  Amplification of IGH/MYC fusion in clinically aggressive IGH/BCL2-positive germinal center B-cell lymphomas.

Authors:  José Ignacio Martín-Subero; María Dolores Odero; Roberto Hernandez; Juan Cruz Cigudosa; Xabier Agirre; Borja Saez; Eduardo Sanz-García; María T Ardanaz; Francisco Javier Novo; Randy D Gascoyne; María José Calasanz; Reiner Siebert
Journal:  Genes Chromosomes Cancer       Date:  2005-08       Impact factor: 5.006

Review 4.  MYC and transcription elongation.

Authors:  Peter B Rahl; Richard A Young
Journal:  Cold Spring Harb Perspect Med       Date:  2014-01-01       Impact factor: 6.915

5.  Myc-driven endogenous cell competition in the early mammalian embryo.

Authors:  Cristina Clavería; Giovanna Giovinazzo; Rocío Sierra; Miguel Torres
Journal:  Nature       Date:  2013-07-10       Impact factor: 49.962

6.  Concurrent translocation of BCL2 and MYC with a single immunoglobulin locus in high-grade B-cell lymphomas.

Authors:  S Knezevich; O Ludkovski; C Salski; V Lestou; M Chhanabhai; W Lam; R Klasa; J M Connors; M J S Dyer; R D Gascoyne; D E Horsman
Journal:  Leukemia       Date:  2005-04       Impact factor: 11.528

7.  Transcriptional amplification in tumor cells with elevated c-Myc.

Authors:  Charles Y Lin; Jakob Lovén; Peter B Rahl; Ronald M Paranal; Christopher B Burge; James E Bradner; Tong Ihn Lee; Richard A Young
Journal:  Cell       Date:  2012-09-28       Impact factor: 41.582

Review 8.  BAG-1 family of cochaperones in the modulation of nuclear receptor action.

Authors:  A C Cato; S Mink
Journal:  J Steroid Biochem Mol Biol       Date:  2001-11       Impact factor: 4.292

9.  Clustered mutations in the second exon of the MYC gene in sporadic Burkitt's lymphoma.

Authors:  T Yano; C A Sander; H M Clark; M V Dolezal; E S Jaffe; M Raffeld
Journal:  Oncogene       Date:  1993-10       Impact factor: 9.867

Review 10.  Socializing with MYC: cell competition in development and as a model for premalignant cancer.

Authors:  Laura A Johnston
Journal:  Cold Spring Harb Perspect Med       Date:  2014-04-01       Impact factor: 6.915

View more
  76 in total

1.  Molecular fine-tuning of affinity maturation in germinal centers.

Authors:  Yee Ling Wu; Cristina Rada
Journal:  J Clin Invest       Date:  2015-12-14       Impact factor: 14.808

2.  Methods for Determining Myc-Induced Apoptosis.

Authors:  Dan Lu; Catherine Wilson; Trevor D Littlewood
Journal:  Methods Mol Biol       Date:  2021

Review 3.  MYC cofactors: molecular switches controlling diverse biological outcomes.

Authors:  Stephen R Hann
Journal:  Cold Spring Harb Perspect Med       Date:  2014-06-17       Impact factor: 6.915

4.  The MYC Oncogene Cooperates with Sterol-Regulated Element-Binding Protein to Regulate Lipogenesis Essential for Neoplastic Growth.

Authors:  Arvin M Gouw; Katherine Margulis; Natalie S Liu; Sudha J Raman; Anthony Mancuso; Georgia G Toal; Ling Tong; Adriane Mosley; Annie L Hsieh; Delaney K Sullivan; Zachary E Stine; Brian J Altman; Almut Schulze; Chi V Dang; Richard N Zare; Dean W Felsher
Journal:  Cell Metab       Date:  2019-08-22       Impact factor: 27.287

Review 5.  Multiple oncogenic roles of nuclear beta-catenin.

Authors:  Raju Kumar; Murali D Bashyam
Journal:  J Biosci       Date:  2017-12       Impact factor: 1.826

6.  Smarcal1 and Zranb3 Protect Replication Forks from Myc-Induced DNA Replication Stress.

Authors:  Matthew V Puccetti; Clare M Adams; Saul Kushinsky; Christine M Eischen
Journal:  Cancer Res       Date:  2019-01-04       Impact factor: 12.701

7.  Targeting ubiquitin-activating enzyme induces ER stress-mediated apoptosis in B-cell lymphoma cells.

Authors:  Scott Best; Taylor Hashiguchi; Adam Kittai; Nur Bruss; Cody Paiva; Craig Okada; Tingting Liu; Allison Berger; Alexey V Danilov
Journal:  Blood Adv       Date:  2019-01-08

8.  Developmental vascular regression is regulated by a Wnt/β-catenin, MYC and CDKN1A pathway that controls cell proliferation and cell death.

Authors:  Gowri Nayak; Yoshinobu Odaka; Vikram Prasad; Alyssa F Solano; Eun-Jin Yeo; Shruti Vemaraju; Jeffery D Molkentin; Andreas Trumpp; Bart Williams; Sujata Rao; Richard A Lang
Journal:  Development       Date:  2018-06-14       Impact factor: 6.868

9.  AGO2 Mediates MYC mRNA Stability in Hepatocellular Carcinoma.

Authors:  Kai Zhang; Yotsawat Pomyen; Anna E Barry; Sean P Martin; Subreen Khatib; Lucy Knight; Marshonna Forgues; Dana A Dominguez; Ravinder Parhar; Ashesh P Shah; Adam S Bodzin; Xin Wei Wang; Hien Dang
Journal:  Mol Cancer Res       Date:  2020-01-15       Impact factor: 5.852

10.  Folliculin Interacting Protein 1 Maintains Metabolic Homeostasis during B Cell Development by Modulating AMPK, mTORC1, and TFE3.

Authors:  Julita A Ramírez; Terri Iwata; Heon Park; Mark Tsang; Janella Kang; Katy Cui; Winnie Kwong; Richard G James; Masaya Baba; Laura S Schmidt; Brian M Iritani
Journal:  J Immunol       Date:  2019-11-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.